Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R01HL104608, R01HL141992, K01HL140218, X01HL134589, R01HL117004, R01HL135156, R01HL128439)
National Institute of Environmental Health Sciences (R21ES24844, R01ES015794)
National Institute on Minority Health and Health Disparities (R01MD010443, RL5GM118984, P60MD006902)
Tobacco-Related Disease Research Program (24RT-0025)
Gordon and Betty Moore Foundation (GBMF3834,)
National Institutes of Health (T34GM008574)
National Institute of General Medical Sciences (TL4GM118986, RL5GM118984, 1UL1GM118985)
Received: 5 March 2020
Accepted: 23 June 2020
First Online: 3 July 2020
Ethics approval and consent to participate
: A total of 617 participants from the SAGE study were used to generate the results described in this manuscript. The SAGE study was approved by the Institutional Review Board of the University of California San Francisco (Laurel Heights Panel) (IRB# 10–02877; Reference # 271317). All participants 18 years of age at the time of study enrollment provided their written consent to participate in this study. Parents of participants under 18 years of age provided their written assent for the participation of their children in this study.
: Not Applicable.
: The authors declare that they have no competing interests.